The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Cardiovascular comorbidity and its impact on patients with COVID-19
Open accessAbstract
We truly appreciate the comments from C.E. Leiva Sisnieguez and colleagues, who have performed a further analysis on the potential association between cardiovascular comorbidities and the clinical outcomes of coronavirus disease 2019 (COVID-19), particularly the mortality). We also applaud the suggestion to thoroughly adjust for potential confounding factors when interpreting the association between specific categories of cardiovascular comorbidities ( e.g. hypertension) and the clinical outcomes of COVID-19. To this end, we have attempted to incorporate the cardiovascular diseases (including coronary heart disease) into the multivariate regression model [1]. Findings of the model indicated a prominent collinearity between hypertension and coronary heart disease, and we have therefore elected to retain hypertension in the regression model for further analyses. Comorbid hypertension correlates with poorer outcomes in patients with COVID-19
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comorbidity and its impact on 1590 patients with covid-19 in China: a nationwide analysis
Guan, W.-J., Liang, W.-H., Zhao, Y., Liang, H.-R., Chen, Z.-S., Li, Y.-M., Liu, X.-Q., Chen, R.-C., Tang, C.-L., Wang, T., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.00547-2020 · Cited by 3,680
Self-citationClinical Features and Short-term Outcomes of 144 Patients With SARS in the Greater Toronto Area
Booth, C. M. (2003) · JAMA · doi:10.1001/jama.289.21.joc30885 · Cited by 1,406
Badawi, A., & Ryoo, S. G. (2016) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2016.06.015 · Cited by 703
Alqahtani, F. Y., Aleanizy, F. S., Mohamed, R. A. E. H., Alanazi, M., Mohamed, N., Al-Rasheed, M. M., Abanmy, N. O., & Alhawassi, T. M. (2018) · Epidemiology and Infection · doi:10.1017/s0950268818002923 · Cited by 147
Arterial hypertension and the risk of severity and mortality of COVID-19
Sisnieguez, C. E. L., Espeche, W. G., & Salazar, M. R. (2020) · European Respiratory Journal · doi:10.1183/13993003.01148-2020 · Cited by 51
Diabetes Mellitus, Hypertension, and Death among 32 Patients with MERS-CoV Infection, Saudi Arabia
Alanazi, K. H., Abedi, G. R., Midgley, C. M., Alkhamis, A. M., Alsaqer, T. A., Almoaddi, A., Algwizani, A. R., Ghazal, S., Assiri, A. M., Jokhdar, H., et al. (2019) · Emerging infectious diseases · doi:10.3201/eid2601.190952 · Cited by 47
Placzek, H., & Madoff, L. C. (2014) · American Journal of Public Health · doi:10.2105/ajph.2014.302197 · Cited by 25
Cited by
Comorbidity and its Impact on Patients with COVID-19
Sanyaolu, A., Okorie, C., Marinkovic, A., Patidar, R., Younis, K., Desai, P., Hosein, Z., Padda, I., Mangat, J., & Altaf, M. (2020) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-020-00363-4 · Cited by 1,548
Knight, S. R., Ho, A., Pius, R., Buchan, I., Carson, G., Drake, T. M., Dunning, J., Fairfield, C. J., Gamble, C., Green, C. A., et al. (2020) · BMJ · doi:10.1136/bmj.m3339 · Cited by 1,029
Biomarkers associated with COVID-19 disease progression
Ponti, G., Maccaferri, M., Ruini, C., Tomasi, A., & Ozben, T. (2020) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2020.1770685 · Cited by 890
Alqahtani, J. S., Oyelade, T., Aldhahir, A. M., Alghamdi, S. M., Almehmadi, M., Alqahtani, A. S., Quaderi, S., Mandal, S., & Hurst, J. R. (2020) · PLOS ONE · doi:10.1371/journal.pone.0233147 · Cited by 858
Antonelli, M., Penfold, R. S., Merino, J., Sudre, C. H., Molteni, E., Berry, S., Canas, L. S., Graham, M. S., Klaser, K., Modat, M., et al. (2022) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(21)00460-6 · Cited by 843
Metadata
- Authors
- Guan, W.-J., Liang, W.-H., He, J.-X., & Zhong, N.-S.
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2020-04-27
- Volume
- 55
- Issue
- 6
- Pages
- 2001227
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W3017792836
- Cited by
- 618
- References
- 7
- FWCI
- 16.33
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.